AAA May 2013 – Page 4

AesRx banks $1.36m

AesRx, a US-based biopharmaceutical company backed by MedImmune Ventures (wholly-owned corporate venturing fund within the AstraZeneca Group, founded in 2002 for investing in emerging healthcare), has raised $1.36m convertible debt out of a $1.53m offering, according to a 9 May regulatory filing. AesRX is also backed by Fidelity Biosciences, a venture capital division of mututal… Continue reading AesRx banks $1.36m

Wayra UnLtd calls for answers to UK social problems

Wayra UnLtd, the joint venture between Telefónica’s technology incubator unit Wayra UK and the UK charitable organization UnLtd (provider of support to social entrepreneurs in the UK), announced on 9 May 2013 that it was open to submissions from UK early stage digital social ventures. Applications are being taken until mid-June; shortlisted candidates will be… Continue reading Wayra UnLtd calls for answers to UK social problems

Power brokers connect

Sometimes it feels as if I have the greatest job in the world, and this week is definitely one of those times. We’ve more than 250 corporate venturing Power Brokers registered for our third annual Symposium this week with aggregate corporate revenues of more than $3.5 trillion ($3687.7bn) and about $100bn in venturing assets.  These are quite… Continue reading Power brokers connect